Literature DB >> 33800596

Trends and Dynamics in the First Four Years of Operation of the First Human Milk Bank in Vietnam.

Hoang Thi Tran1,2, Tuan Thanh Nguyen3, Debbie Barnett4, Gillian Weaver5, Oanh Thi Xuan Nguyen1, Quang Van Ngo6, Huong Thi Thanh Le1, Le Thi Huynh1,2, Chung Thi Do3, Roger Mathisen3.   

Abstract

BACKGROUND: Since 1979, the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF) have recommended the use of pasteurized human milk from a human milk bank (HMB) to feed low birthweight (LBW) and preterm newborns as the 'first alternative' when mothers are unable to provide their own milk. However, they have not issued any guidelines for the safe establishment and operation of an HMB. This gap contributes to the demand for gathering experiences from HMB networks, especially those from lower-middle income countries. To fill this knowledge gap, this study examines the characteristics of donors, donation, pasteurization, and recipients during the first four years of operation in the first HMB in Vietnam.
METHODS: Data about the donors, donation, pasteurization, and recipients were extracted from the web-based electronic monitoring system of the HMB from 1 February 2017 to 31 January 2021.
RESULTS: In the first four years of operation there were 433 donors who donated 7642 L of milk (66% from the community) with an increased trend in the amount of donated milk, donation duration, and average amount of milk donated by a donor. Approximately 98% of the donated milk was pasteurized, and 82% passed both pre- and post-pasteurization tests. Although the pass rate tended to increase with time, a few dips occurred. Of 16,235 newborns who received pasteurized donor milk, two thirds were in the postnatal wards. The main reason for the prescription of pasteurized donor milk was insufficient mothers' own milk in the first few days after birth. There was a decreased trend in the amount and duration of using pasteurized donor milk in both postnatal wards and the neonatal unit.
CONCLUSIONS: The HMB has operated efficiently in the previous four years, even during the COVID-19 pandemic, to serve vulnerable newborns. Ongoing evidence-based adjustments helped to improve the operation to recruit suitable donors, to increase the access to and quality of raw donor milk, to improve the pasteurization process, and to meet the need of more newborns.

Entities:  

Keywords:  COVID-19; breastfeeding; donor milk; early essential newborn care (EENC); human milk bank; newborn; prelacteal feeding

Mesh:

Year:  2021        PMID: 33800596     DOI: 10.3390/nu13041107

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  4 in total

1.  Implementation of two policies to extend maternity leave and further restrict marketing of breast milk substitutes in Vietnam: a qualitative study.

Authors:  Denise Diaz Payán; Neha Zahid; Jeffrey Glenn; Ha Tt Tran; Tran Thi Thu Huong; Corrina Moucheraud
Journal:  Health Policy Plan       Date:  2022-04-13       Impact factor: 3.344

2.  Eight-year operation status and data analysis of the first human milk bank in East China.

Authors:  Hu Xiaoshan; Chu Xue; Zhang Jun; Liu Feng; Chen Xiaohui; Yu Zhangbin; Han Shuping
Journal:  Int Breastfeed J       Date:  2022-09-01       Impact factor: 3.790

3.  Implementation and Effectiveness of Policies Adopted to Enable Breastfeeding in the Philippines Are Limited by Structural and Individual Barriers.

Authors:  Jyn Allec R Samaniego; Cherry C Maramag; Mary Christine Castro; Paul Zambrano; Tuan T Nguyen; Janice Datu-Sanguyo; Jennifer Cashin; Roger Mathisen; Amy Weissman
Journal:  Int J Environ Res Public Health       Date:  2022-09-01       Impact factor: 4.614

4.  Factors Associated with the Use of Pasteurized Donor Milk for Healthy Newborns: Experience from the First Human Milk Bank in Vietnam.

Authors:  Hoang Thi Tran; Tuan T Nguyen; Hoang Thi Nam Giang; Le Thi Huynh; Debbie Barnett; Roger Mathisen; John C S Murray
Journal:  Nutrients       Date:  2021-03-31       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.